Highly effective antiobesity and diabetes medications such as glucagon-like peptide 1 (GLP-1) agonists have ushered in a new era of treatment of these highly prevalent, morbid conditions that have increased across the globe over the past few decades. The gene discussed is GCG; the disease is diabetes mellitus.